Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Harvard Bioscience Completes Genomics Solutions Acquisition

Oct. 28, 2002

By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002

By Aaron Lorenzo

OSI Drops Diabetes Program, Puts Full Focus On Oncology

Oct. 25, 2002

By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002

By Aaron Lorenzo

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Oct. 24, 2002

By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002

By Aaron Lorenzo

Incara Divests Liver Program Via Sale To Vesta Therapeutics

Oct. 23, 2002

By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002

By Aaron Lorenzo

ICOS, Texas Biotechnology Plan FDA Meeting On PAH Drug

Oct. 22, 2002

By Aaron Lorenzo

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Oct. 8, 2002

By Aaron Lorenzo

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...